Re-dosing of del Nido cardioplegia in adult cardiac surgery requiring prolonged aortic cross-clamp |
| |
| Authors: | Alex M D’ Angelo,Samantha Nemeth,Catherine Wang,Alexander P Kossar,Koji Takeda,Hiroo Takayama,Vinayak Bapat,Yoshifumi Naka,Michael Argenziano,Craig R Smith,James Beck,Jessica Spellman,Paul Kurlansky,Isaac George |
| |
| Affiliation: | 1. Department of Surgery, Columbia University Medical Center, New York, NY, USA;2. Center for Innovation and Outcomes Research, Columbia University, New York, NY, USA;3. Department of Cardiothoracic Surgery, Abbott Northwestern Hospital, Minneapolis, MN, USA;4. Department of Anesthesiology, Columbia University Medical Center, New York, NY, USA |
| |
| Abstract: | Open in a separate window OBJECTIVESFew data exist on the use of del Nido cardioplegia in adults, specifically during operations requiring prolonged aortic cross-clamp. In this pilot study, we evaluate outcomes of patients undergoing surgery with cross-clamp time >3 h based on re-dosing strategy, using either full dose (FD; 1:4 blood to crystalloid ratio) or dilute (4:1 blood to crystalloid ratio) solution.METHODSConsecutive adult patients (>18 years) undergoing cardiac surgery from 2012 to 2018 with cross-clamp time >3 h were reviewed. Patients were excluded if del Nido cardioplegia was not used. Patients were categorized into FD or dilute groups based on re-dosing solution. Propensity score matching was used to control for baseline differences between groups. The primary endpoint was in-hospital mortality. Other outcomes examined included: postoperative mechanical support, arrhythmia, stroke, dialysis and cardiac function.RESULTSIncluded for analysis were 173 patients (115 male) with median age of 63.8 (interquartile range 53.9–73.1). Major comorbidities included diabetes (45), cerebrovascular disease (34), hypertension (131), atrial fibrillation (52) and previous cardiac surgery (83). There were 108 patients (62%) who received FD re-dosing, while 65 (38%) received dilute. A greater proportion of patients in the dilute group received retrograde delivery, for both induction (32/108 vs 39/65, P < 0.001) and re-dose (50/108 vs 53/65, P < 0.001). After propensity score matching, in-hospital mortality was not different between groups (6/48 vs 1/48, P = 0.131). There were no differences in rates of postoperative mechanical circulatory support, stroke, left ventricular ejection fraction or right ventricle dysfunction.CONCLUSIONSDel Nido cardioplegia has been used in complex cardiac surgery requiring prolonged cross-clamp. Re-dosing can be performed with either FD or dilute del Nido solution with no statistical difference in outcomes. |
| |
| Keywords: | Myocardial protection Cardioplegia Del Nido cardioplegia |
|
|
